StonvexLoading…
StonvexStonvexStonvexCore line items from TRS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $168.28M | $645.72M | $785.69M | $516.43M |
Operating Income | $6.89M | $41.30M | $65.50M | $48.91M |
Net Income | $800.83M | $120.14M | $9.30M | $16.72M |
EPS (Diluted) | $21.40 | $2.95 | $0.23 | $0.41 |
Total Assets | $2.30B | $1.49B | $1.43B | $1.45B |
Total Liabilities | $847.32M | $779.49M | $708.84M | $730.13M |
Cash & Equivalents | $1.31B | $30.02M | $33.64M | $30.28M |
Free Cash Flow OCF − CapEx | $-24.60M | $69.10M | $32.28M | $9.46M |
Shares Outstanding | 36.34M | 37.63M | 40.64M | 40.64M |